The study focused on the association between triglyceride metabolism and mortality risk, suggesting that the vigor of TG metabolism, rather than plasma levels, is linked to adverse outcomes. The analysis, based on 30,000 participants, found increased risks for all-cause mortality, cardiovascular mortality, and cancer mortality among those with robust TG metabolism. The study highlighted the significance of glycerol and β-hydroxybutyrate concentrations as markers of TG metabolic rate, independent of traditional risk factors like BMI and plasma TG levels. The findings challenge conventional beliefs about TG and mortality risk, emphasizing the need to consider metabolic rate in risk assessments.
toiselle kielelle
lähdeaineistosta
www.medscape.com
Tärkeimmät oivallukset
by Steve Stiles klo www.medscape.com 08-23-2023
https://www.medscape.com/viewarticle/995764Syvällisempiä Kysymyksiä